NCT02805881View on ClinicalTrials.gov

Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Major Depressive Disorder
Interventions
DEVICE

Neurolief system

Non-invasive cephalic neurostimulation device

Trial Locations (1)

Unknown

Beer- Yakov Nees-Ziona Mental Health Center, Ness Ziona

Sponsors

Lead Sponsor

Neurolief Ltd.
All Listed Sponsors
lead

Neurolief Ltd.

INDUSTRY

NCT02805881 - Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD) | Biotech Hunter | Biotech Hunter